CLOSE

At least this should be the BMI, a lower number also invites heart disease



New York, February 16, 2023, Thursday

It is generally believed that thinner people are less prone to heart disease. According to a research report in the journal Science, those who have a body mass index of less than 18.5 and are addicted to cigarettes are more likely to develop heart disease. When BMI is between 22 and 23, chances are low. Body mass index is the ratio between a person's height and weight. Currently, BMI has become an international measure of fatness. By which the condition of health can be known. However, BMI score is not applicable to pregnant women.

According to the World Health Organization, a BMI of 18.5 to 24 is healthy and a BMI of 25 to 30 is overweight, while a BMI of more than 30 falls into the category of obesity. The study found that people with a BMI greater than 23 had a higher risk of the disease. In particular, those with excess waist fat were found to be at greater risk. People with a BMI greater than 25 have a 13 percent increased risk of heart disease. However, researchers say that being underweight similarly increases the risk of heart disease. Hence BMI should be neutral in relation to weight and height.


Comments

Popular posts from this blog

World Hypertension Day: Know the symptoms of hypertension and how to prevent it

Does your urine smell? Know the symptoms somewhere urea is not increasing

Eating these 4 foods is bad for mental health! Stop eating from today

Why is rice washed before cooking? Know its scientific reason

Traffic noise makes a person suffer from high BP, living in noisy area is also dangerous. Study

AC in the office increases the working speed of employees by 12%. Find out what the AC temperature should be

More than 1 billion people in the world have high BP, 50% do not know they have BP

Why is it necessary to wear supporter in the gym? Know the reason

Some benefits of calcium in the body, if it decreases, what will be the harm? Know the details

Black wheat will be marketed as medicine for diabetes, cancer and heart patients